tiprankstipranks
Trending News
More News >
Shin Nippon Biomedical Laboratories, Ltd. (JP:2395)
:2395
Japanese Market
Advertisement

Shin Nippon Biomedical Laboratories, Ltd. (2395) Revenue

Compare
2 Followers

Shin Nippon Biomedical Laboratories, Ltd. Revenue

Shin Nippon Biomedical Laboratories, Ltd. had a revenue of 10.18B in the quarter ending Mar 31, 2025, with 4.64%. This bring the company's revenue in the last twelve months to 32.41B, Decreased 5.58%. In the fiscal year ending Dec 31, 2024, Shin Nippon Biomedical Laboratories, Ltd. had annual revenue of 32.41B with 22.55% growth.
Revenue (ttm)
32.41B
Revenue Growth
27.28%
P/S Ratio
2.24
Revenue/Employee
¥22,246,951
Employees
1,457
Market Cap
¥72.48B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
32.41B5.96B+22.55%
Dec 31, 2023
26.45B1.36B+5.42%
Dec 31, 2022
25.09B7.34B+41.37%
Dec 31, 2021
17.75B2.64B+17.46%
Dec 31, 2020
15.11B549.46M+3.77%
Dec 31, 2019
14.56B-1.10B-7.01%
Dec 31, 2018
15.66B-941.87M-5.67%
Dec 31, 2017
16.60B-643.95M-3.73%
Dec 31, 2016
17.24B
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis